Comparing the Cost of Treatment with Octreotide Long-Acting Release versus Lanreotide in Patients with Metastatic Gastrointestinal Neuroendocrine Tumors

Ayyagari, R; Neary, M; Li, S; Rokito, A; Yang, HB; Xie, JP; Benson, AB

Ayyagari, R (reprint author), Anal Grp, Boston, MA 02199 USA.

AMERICAN HEALTH AND DRUG BENEFITS, 2017; 10 (8): 408

Abstract

BACKGROUND: The 2 somatostatin analogs currently recommended by the National Comprehensive Cancer Network for the treatment of gastrointestinal (GI) n......

Full Text Link